Boston Scientific's estimated fair value is US$74.57 based on 2 Stage Free Cash Flow to Equity Current share price of US$99.74 suggests Boston Scientific is potentially 34% overvalued Our fair value ...

Recently, Veeva Systems (NYSE: VEEV) — a cloud-computing enterprise focused on pharmaceutical and life sciences industry ...

In this article, we are going to take a look at where Boston Scientific Corporation (NYSE:BSX) stands against other best fundamental stocks to buy now. The S&P 500 index closed 0.3% lower at 6,101 ...

Investors interested in Medical - Products stocks are likely familiar with Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two stocks is more attractive to value investors?